Advertisement
Advertisement

PRAX

PRAX logo

Praxis Precision Medicines, Inc. Common Stock

310.23
USD
Sponsored
+4.86
+1.59%
Jun 24, 11:25 UTC -4
Open

Praxis Precision Medicines, Inc. Common Stock Profile

About

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Marcio Souza

Headquarters

99 HIGH STREET, 30TH FLOOR
BOSTON, MA 02110, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.praxismedicines.com

Auditor

Ernst & Young LLP

Share holders

2

Employees

168

Praxis Precision Medicines, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

8.65B

Enterprise Value

8.11B

Enterprise Value/EBITDA(ttm)

-22.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-58.74%

Return on Invested Capital(ttm)

-65.02%

Return on Assets(ttm)

-53.54%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-360.22M

Net Income Available to Common(ttm)

-326.53M

Diluted EPS(ttm)

-13.46

Share Statistics

Beta (5Y Monthly)

2.94

52-Week Change

645.21%

S&P 500 52-Week Change

21.69%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

27.88M

Dividend Yield

0.00%

Float4

27.10M

% Held by Insiders

2.70%

% Held by Institutions

67.84%

Balance Sheet

Total Cash(mrq)

786.87M

Total Cash Per Share(mrq)

28.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.22%

Quick Ratio(mrq)

10.22%

Book Value Per Share(mrq)

34.85

Cash Flow

Operating Cash Flow Per Share(ytd)

-11.07

Free Cash Flow(ytd)

-249.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement